Pancreatic Cancer Research

ResearcherNorwalk HospitalActive in the last 2 years

Richard C. Frank

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5923-7171; OpenAlex author ID A5018212344. Sources: ClinicalTrials.gov.

Their work

Papers
8 (first author 0, last author 4)
Trials
3 (principal investigator on 3)
Grants
0
Labs led
1
Collaborators
31
Papers, trials and grants by year

2015: 1 paper, 1 trial · 2016: 1 trial · 2017: none · 2018: 1 trial · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 8

  1. A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancre… Co-author DOI 10.1002/cncr.70343↗
  2. Serial proteomic analysis identifies small extracellular vesicle-MASP2 as an early biomarker of chemotherapy response in advanced pancreatic cancer. Last author DOI 10.1016/j.tranon.2025.102636↗
  3. Pancreatic Cancer Screening in New-onset and Deteriorating Diabetes: Preliminary Results From the PANDOME Study. Co-author DOI 10.1210/clinem/dgaf319↗
  4. A Community-Based Pancreatic Cancer Screening Study in High-Risk Individuals: Preliminary Efficacy and Safety Results. Last author DOI 10.14309/ctg.0000000000000516↗
  5. Glycemic Control as an Early Prognostic Marker in Advanced Pancreatic Cancer. Last author DOI 10.3389/fonc.2021.571855↗
  6. ATM-Mutated Pancreatic Cancer: Clinical and Molecular Response to Gemcitabine/Nab-Paclitaxel After Genome-Based Therapy Resistance. Last author DOI 10.1097/mpa.0000000000001461↗
  7. Subacute cutaneous lupus erythematosus induced by gemcitabine in 2 patients with pancreatic cancer. Co-author DOI 10.1016/j.jdcr.2019.04.020↗
  8. (90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior ther… Co-author DOI 10.1016/j.ejca.2015.06.119↗

Trials 3

  1. A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus Principal investigator NCT03937453↗
  2. A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals Principal investigator NCT03250078↗
  3. The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer Principal investigator NCT04406831↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dugho Jin · 2 shared papers, 2022–2025 · strength 0.34
  2. Shatovisha Dey · 1 shared paper, 2026 · strength 0.26
  3. Daniel D. Von Hoff · 2 shared papers, 2015–2026 · strength 0.25
  4. Derek Cridebring · 1 shared paper, 2026 · strength 0.22
  5. Gayle Jameson · 1 shared paper, 2026 · strength 0.22
  6. Drew Warren Rasco · 1 shared paper, 2026 · strength 0.22
  7. Joshua D. Rabinowitz · 1 shared paper, 2026 · strength 0.22
  8. Erkut Hasan Borazanci · 1 shared paper, 2026 · strength 0.22
  9. Angela Tatiana Alistar · 1 shared paper, 2026 · strength 0.22
  10. Diana L. Hanna · 1 shared paper, 2026 · strength 0.22
  11. Ipek Alpertunga · 1 shared paper, 2021 · strength 0.13
  12. Jonathan Kandiah · 1 shared paper, 2022 · strength 0.13
  13. Candice Martino · 1 shared paper, 2020 · strength 0.13
  14. Matthew A. Cornacchia · 1 shared paper, 2019 · strength 0.12
  15. Charles L. Halasz · 1 shared paper, 2019 · strength 0.12
  16. Neeta D. Pandit-Taskar · 1 shared paper, 2015 · strength 0.03
  17. Alexander Starodub · 1 shared paper, 2015 · strength 0.03
  18. Bert H. O’Neil · 1 shared paper, 2015 · strength 0.03
  19. Donald Richards · 1 shared paper, 2015 · strength 0.03
  20. Eileen Mary O'Reilly · 1 shared paper, 2015 · strength 0.03
  21. Ronald Lee Korn · 1 shared paper, 2015 · strength 0.03
  22. Fa-Chyi Lee · 1 shared paper, 2015 · strength 0.03
  23. Fadi Braiteh · 1 shared paper, 2015 · strength 0.03
  24. Allyson J. Ocean · 1 shared paper, 2015 · strength 0.03
  25. Ramesh K. Ramanathan · 1 shared paper, 2015 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.